Macromolecular Drug Targets in Cancer Treatment and Thiosemicarbazides as Anticancer Agents

Area of Science:

• Medicinal Chemistry
• Organic Chemistry
• Pharmacology

Background:

• Cancer is characterized by abnormal cell division, necessitating targeted therapies beyond traditional chemotherapy and radiotherapy.
• Current research emphasizes developing anticancer drugs that selectively target cancer cells, minimizing damage to healthy tissues.
• Heterocyclic molecules play a crucial role in pharmaceutical drug design and healthcare.

Purpose of the Study:

• To explore the potential of thiosemicarbazides as a novel class of anticancer agents.
• To highlight the structural features of thiosemicarbazides that contribute to their diverse biological activities.
• To underscore the growing importance of thiosemicarbazides in antineoplastic drug discovery.

Main Methods:

• Review of existing literature on thiosemicarbazide synthesis and biological activities.
• Analysis of the chemical structure of thiosemicarbazides and their functional groups (amide, amine, thione).
• Investigation of reported pharmacological properties including anticonvulsant, antiviral, anti-inflammatory, antibacterial, antifungal, antioxidant, and anticancer activities.

Main Results:

• Thiosemicarbazides exhibit a broad spectrum of biological activities, including potent anticancer effects.
• The presence of specific functional groups in thiosemicarbazide structures is key to their therapeutic potential.
• Several thiosemicarbazide derivatives have shown promise as antineoplastic agents, with some already available commercially.

Conclusions:

• Thiosemicarbazides represent a promising scaffold for the development of new, targeted anticancer drugs.
• Further research into thiosemicarbazide derivatives is warranted to optimize their efficacy and safety in cancer treatment.
• The unique chemical properties of thiosemicarbazides make them valuable candidates for novel drug discovery in oncology.